original ) (raw )Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial
Christian Torp-pedersen
The Lancet, 2003
View PDFchevron_right
Death and hospitalization in heart failure patients receiving carvedilol vs. metoprolol tartrate
May Hagiwara
International Journal of Cardiology, 2005
View PDFchevron_right
Effects of metoprolol and carvedilol on cause-specific mortality and morbidity in patients with chronic heart failure—COMET
Allan Skene
American Heart Journal, 2005
View PDFchevron_right
Differential Effects of -Blockers in Patients With Heart Failure : A Prospective, Randomized, Double-Blind Comparison of the Long-Term Effects of Metoprolol Versus Carvedilol
Savina Nodari
Circulation, 2000
View PDFchevron_right
Carvedilol in the treatment of chronic heart failure: Lessons from The Carvedilol Or Metoprolol European Trial
Buris Christiansen
2007
View PDFchevron_right
Differential effects of beta-blockers in patients with heart failure: A prospective, randomized, double-blind comparison of the long-term effects of metoprolol versus carvedilol
Savina Nodari
Circulation, 2000
View PDFchevron_right
Carvedilol Compared to Metoprolol Succinate in the Treatment and Prognosis of Patients With Stable Chronic Heart Failure: The Carvedilol or Metoprolol Evaluation Study (COMES)
Dan Atar
Circulation. Heart failure, 2015
View PDFchevron_right
Carvedilol Compared With Metoprolol Succinate in the Treatment and Prognosis of Patients With Stable Chronic Heart Failure
Dieter Schellberg
Circulation-heart Failure, 2015
View PDFchevron_right
The Effect of Carvedilol on Morbidity and Mortality in Patients with Chronic Heart Failure
Michael B
New England Journal of Medicine, 1996
View PDFchevron_right
Comparative Effectiveness of Beta-Adrenergic Antagonists (Atenolol, Metoprolol Tartrate, Carvedilol) on the Risk of Rehospitalization in Adults With Heart Failure
Kimberly Lane
The American Journal of Cardiology, 2007
View PDFchevron_right
Carvedilol in the treatment of chronic heart failure
Gordon Moe
Expert Opinion on Pharmacotherapy, 2001
View PDFchevron_right
Effect of Carvedilol on Survival in Severe Chronic Heart Failure
P. Mohacsi
New England Journal of Medicine, 2001
View PDFchevron_right
Randomized, Double-Blind Comparison of Acute ? 1 -Blockade With 50 mg Metoprolol Tartrate vs 25 mg Carvedilol in Normal Subjects
Krishnan Ramanathan
Congestive Heart Failure, 2006
View PDFchevron_right
Effects of Initiating Carvedilol in Patients With Severe Chronic Heart Failure
Andrew Coats
JAMA, 2003
View PDFchevron_right
Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): …
Marco Metra
The Lancet, 2003
View PDFchevron_right
Bisoprolol compared with carvedilol and metoprolol succinate in the treatment of patients with chronic heart failure
Torstein Hole
Clinical research in cardiology : official journal of the German Cardiac Society, 2017
View PDFchevron_right
Choosing metoprolol or carvedilol in heart failure (a pre-COMET commentary
Radha Gopalan
American Journal of Cardiology, 2003
View PDFchevron_right
Baseline predictors of tolerability to carvedilol in patients with chronic heart failure
Peter Macdonald
Heart, 2000
View PDFchevron_right
Tolerability and efficacy of carvedilol in patients with New York Heart Association class IV heart failure
Christina Aboyoun
Journal of the American College of Cardiology, 1999
View PDFchevron_right
Effect of carvedilol and metoprolol on the mode of death in patients with heart failure
Christian Torp-pedersen , Leif Erhardt
European Journal of Heart Failure, 2007
View PDFchevron_right
Effects of carvedilol in heart failure due to dilated cardiomyopathy. Results of a double-blind randomized placebo-controlled study (CARIBE study)
Paulo Chizzola , Claudio Meneghetti
Arquivos Brasileiros de Cardiologia, 2000
View PDFchevron_right
β-Receptor Selectivity of Carvedilol and Metoprolol Succinate in Patients with Heart Failure (SELECT Trial): A Randomized Dose-Ranging Trial
Mark Munger
Pharmacotherapy, 2009
View PDFchevron_right
Bisoprolol vs. carvedilol in elderly patients with heart failure: rationale and design of the CIBIS-ELD trial
Ferenc Follath
Clinical Research in Cardiology, 2008
View PDFchevron_right
Influence of pretreatment systolic blood pressure on benefit from carvedilol in severe chronic heart failure patients
P. Mohacsi
Journal of the American College of Cardiology, 2005
View PDFchevron_right
Impact of a Standardized Titration Protocol with Carvedilol in Heart Failure: Safety, Tolerability, and Efficacy—A Report from the GESICA Registry
Hugo Grancelli
Cardiovascular Drugs and Therapy, 2005
View PDFchevron_right
Carvedilol in the treatment of elderly patients with chronic heart failure
Klaus Witte
Clinical interventions in aging, 2008
View PDFchevron_right
A Comparison of the Effects of Carvedilol and Metoprolol on Well-Being, Morbidity, and Mortality (the “Patient Journey”) in Patients With Heart Failure
Leif Erhardt
Journal of the American College of Cardiology, 2006
View PDFchevron_right
Association class IV heart failure Tolerability and efficacy of carvedilol in patients with New York Heart
Peter Macdonald
2010
View PDFchevron_right
Treatment of chronic heart failure with carvedilol in daily practice: The SATELLITE survey experience
Norbert Schön
International Journal of Cardiology, 2007
View PDFchevron_right
Titration to target dose of bisoprolol vs. carvedilol in elderly patients with heart failure: the CIBIS-ELD trial
Mirjana Krotin
European Journal of Heart Failure, 2011
View PDFchevron_right